Join
Live feed
·
INSIDERFilingvia Quantisnow
Adamas Pharmaceuticals, Inc. logo

SEC Form 4: Papapetropoulos Spyridon was granted 5,000 units of Common Stock, increasing direct ownership by 31% to 20,975 units

ByQuantisnow·Wall Street's wire, on your screen.
ADMS· Adamas Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADMS (Adamas Pharmaceuticals, Inc.) and more on Quantisnow.